Skip to main content
Clinical Trials/NCT07374952
NCT07374952RecruitingPhase 4

Minimum Effective Volume of Lidocaine for Double-Injection Ultrasound-Guided Costoclavicular Block

McGill University Health Centre/Research Institute of the McGill University Health Centre1 site in 1 country60 target enrollmentStarted: June 16, 2026Last updated:
Interventions

Trial Snapshot

Phase
Phase 4
Status
Recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Success rate

Study Overview

Brief Summary

In 2020, a trial demonstrated that a 2-injection technique constitutes the optimal method for the costoclavicular block.

This study aims to determine the minimum amount of medication required to achieve a successful double-injection costoclavicular nerve.

Block dose assignment will be done using an up-and-down sequential method, called the Biased Coin Design (BCD).

The double-injection technique for US-guided costoclavicular block consists in depositing two thirds of the LA volume in the deep compartment (to anesthetize the posterior and medial cords), and one third of the injectate in the superficial compartment (to anesthetize the lateral cord).

The ED90 will be calculated using isotonic regression with a 95% confidence interval derived by bootstrapping.

Detailed Description

With the approval of the ethics committee of McGill University Health Centre, a total of 60 patients undergoing upper extremity surgery (elbow or below elbow) will be recruited.

The costoclavicular block will be performed under direct US vision until the tip is between the medial cord and the axillary artery. Two thirds of the volume of LA will be injected in this first location. Subsequently, the needle will be advanced until its tip is positioned next to the lateral cord. The remaining third of the LA volume will be injected in this second location.

Dose assignation will be done using an up-and-down sequential method, where the dose of each subsequent patient depends on the response of the previous patient, called the Biased Coin Design. The first subject recruited will receive a total of 30 mL of lidocaine 1.5 % with epinephrine 1: 200 000. Injection will be carried out by slow increments (5 mL) with negative aspiration between each increment.

The assignment of each subsequent dose will be based on the response of the previous patient as follows: if the previous patient did not have a successful block, the patient will receive the next higher dose, which is the previous dose incremented by 3.0 ml (i.e., an increment of 2.0 mL between the medial cord and the axillary artery, and an increment of 1.0 mL next to the lateral cord). If the previous patient had a successful block, the patient will be randomized to either receive the next lower dose, which is the previous dose decremented by 3.0 ml (i.e., a decrement of 2.0 mL between the medial cord and the axillary artery, and a decrement of 1.0 mL next to the lateral cord), with a probability b = 0.11, or to receive the same previous dose, with a probability 1 - b = 0.89. These are the probabilities required for assigning doses under the BCD for estimating ED90. A maximal dose of 40 mL will not be exceeded to avoid LA toxicity. If the previous patient did not respond and had been given the maximal dose the patient will also get the maximal dose. As soon as we recruit 45 patients with random dose assignment, we will terminate the enrollment procedure.

A research assistant will prepare and administer the injectate using syringes connected to the block needle. The operator and the patient will be blinded to the volume injected.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Sequential
Primary Purpose
Supportive Care
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Masking Description

A research assistant (a licensed anesthesiologist) will prepare the local anesthetic (lidocaine) solutions according to the sequential allocation. The operator, patient, and outcome assessor will remain blinded to the assignment.

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age between 18 and 70 years
  • American Society of Anesthesiologists classification 1-3
  • Body mass index between 20 and 30

Exclusion Criteria

  • Adults who are unable to give their own consent
  • Pre-existing neuropathy (assessed by history and physical examination)
  • Coagulopathy (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. platelets≤ 100, International Normalized Ratio≥ 1.4 or partial prothrombin time ≥ 50)
  • Renal failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. creatinine≥ 100)
  • Hepatic failure (assessed by history and physical examination and, if deemed clinically necessary, by blood work up i.e. transaminases≥ 100)
  • Allergy to LA
  • Pregnancy
  • Prior surgery in the infraclavicular region
  • Chronic pain syndromes requiring opioid intake at home

Arms & Interventions

Costoclavicular block with same previous successful volume

Active Comparator

Patients randomized to this group will receive the same volume that was successful in the previous recruitment.

Intervention: Ultrasound-guided double-injection costoclavicular nerve block with same previous volume (Procedure)

Costoclavicular block with lower volume

Experimental

This group will be randomized to receive a fixed lower volume than the previously successful block.

Intervention: Ultrasound-guided double-injection costoclavicular nerve block with lower volume (Procedure)

Outcomes

Primary Outcomes

Success rate

Time Frame: 30 minutes

The primary outcome is success rate evaluated by the sensorimotor block which is defined as a minimal composite score of at least 14 points (out of a maximum of 16) is achieved at 30 minutes. The sensorimotor block will be assessed every 5 minutes until 30 minutes after the end of local anesthetic injection using a 16-point composite score evaluating sensory and motor block of musculocutaneous, median, radial, and ulnar nerves. Sensation will be assessed with ice in each nerve territory with a 0 to 2 point scale. 0= no block, patients can feel cold; 1= analgesic block, the patient can feel touch but not cold; 2= anesthetic block, the patient cannot feel cold or touch. The motor function will be assessed for each nerve with a 0 to 2 points scale where 0= no motor block; 1= paresis; 2= paralysis. Successful blocks at 30 minutes correlate with a final score ( sum of all individual sensory and motor scores) of at least 14 points out of 16.

Secondary Outcomes

  • Operator level of experience(1 hour before surgery)
  • The number of needle passes(1 hour before surgery)
  • Block performance time(1 hour before surgery)
  • Block onset time(1 hour before surgery)
  • Total anesthesia-related time(1 hour before surgery)
  • Intensity of pain during block procedure(1 hour before surgery)
  • Phrenic nerve block(1 hour after arrival to post anesthesia care unit)

Investigators

Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Julián Aliste

Associate Professor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Study Sites (1)

Loading locations...

Similar Trials